RITEDOSE Trademark

Trademark Overview


On Sunday, November 14, 2021, a trademark application was filed for RITEDOSE with the United States Patent and Trademark Office. The USPTO has given the RITEDOSE trademark a serial number of 97124132. The federal status of this trademark filing is REGISTERED as of Tuesday, February 13, 2024. This trademark is owned by The Ritedose Corporation. The RITEDOSE trademark is filed in the Pharmaceutical Products and Treatment & Processing of Materials Services categories with the following description:

Custom manufacture of pharmaceuticals to the order and specification of others. Repackaging services for others in the field of pharmaceuticals and other preparations for medical or veterinary purposes; Providing contract development and manufacturing organization (CDMO) services, namely, by providing contract manufacturing of pharmaceuticals for specific companies

Pharmaceutical oral liquid preparations for the treatment of colds, allergies, coughs, sinus ailments, fevers, gastrointestinal ailments, digestive ailments, cardiovascular ailments, circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections, neurological problems, insomnia, hair loss, immunologic ailments; Pharmaceutical oral liquid preparations in the nature of analgesics for pain management; Pharmaceutical oral liquid preparations in the nature of oral contraceptives; Blow fill seal containers for medical use sold filled with pharmaceutical oral liquid preparations for the treatment of colds, allergies, coughs, sinus ailments, fevers, gastrointestinal ailments, digestive ailments, cardiovascular ailments, ...
ritedose

General Information


Serial Number97124132
Word MarkRITEDOSE
Filing DateSunday, November 14, 2021
Status700 - REGISTERED
Status DateTuesday, February 13, 2024
Registration Number7305546
Registration DateTuesday, February 13, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements


Goods and ServicesCustom manufacture of pharmaceuticals to the order and specification of others. Repackaging services for others in the field of pharmaceuticals and other preparations for medical or veterinary purposes; Providing contract development and manufacturing organization (CDMO) services, namely, by providing contract manufacturing of pharmaceuticals for specific companies
Goods and ServicesPharmaceutical oral liquid preparations for the treatment of colds, allergies, coughs, sinus ailments, fevers, gastrointestinal ailments, digestive ailments, cardiovascular ailments, circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections, neurological problems, insomnia, hair loss, immunologic ailments; Pharmaceutical oral liquid preparations in the nature of analgesics for pain management; Pharmaceutical oral liquid preparations in the nature of oral contraceptives; Blow fill seal containers for medical use sold filled with pharmaceutical oral liquid preparations for the treatment of colds, allergies, coughs, sinus ailments, fevers, gastrointestinal ailments, digestive ailments, cardiovascular ailments, circulatory ailments, blood anomalies, respiratory ailments, muscular-skeletal disorders, eye disorders, oral-ear-nose and throat problems, parasitic problems, endocrine problems, male and female sexual performance problems, reproductive system problems, urologic and urinary tract problems, hormone deficiencies, skin disorders, infections, neurological problems, insomnia, hair loss, immunologic ailments

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 19, 2021
Primary Code005
First Use Anywhere DateFriday, July 1, 2011
First Use In Commerce DateFriday, July 1, 2011

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, November 19, 2021
Primary Code040
First Use Anywhere DateFriday, July 1, 2011
First Use In Commerce DateFriday, July 1, 2011

Trademark Owner History


Party NameThe Ritedose Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCOLUMBIA, SC 29203

Party NameThe Ritedose Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCOLUMBIA, SC 29203

Party NameThe Ritedose Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCOLUMBIA, SC 29203

Trademark Events


Event DateEvent Description
Tuesday, February 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 13, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, January 9, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, January 8, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, January 8, 2024EXAMINER'S AMENDMENT ENTERED
Monday, January 8, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 8, 2024EXAMINERS AMENDMENT E-MAILED
Monday, January 8, 2024SU-EXAMINER'S AMENDMENT WRITTEN
Tuesday, December 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 1, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 1, 2023NON-FINAL ACTION E-MAILED
Friday, December 1, 2023SU - NON-FINAL ACTION - WRITTEN
Sunday, November 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, November 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, November 5, 2023ASSIGNED TO LIE
Thursday, November 2, 2023NOTICE OF REVIVAL - E-MAILED
Thursday, November 2, 2023PETITION GRANTED - RESPONSE RECEIVED
Monday, October 30, 2023ASSIGNED TO PETITION STAFF
Thursday, September 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 14, 2023TEAS PETITION TO REVIVE RECEIVED
Thursday, June 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 8, 2023NON-FINAL ACTION E-MAILED
Thursday, June 8, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, May 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 9, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 18, 2023USE AMENDMENT FILED
Tuesday, May 9, 2023SOU EXTENSION 1 GRANTED
Monday, March 6, 2023SOU EXTENSION 1 FILED
Monday, May 8, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 18, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, April 18, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, April 18, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, April 18, 2023PETITION TO REVIVE-GRANTED
Tuesday, April 18, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, April 10, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 10, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 24, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 23, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 23, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 13, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 13, 2022NON-FINAL ACTION E-MAILED
Wednesday, April 13, 2022NON-FINAL ACTION WRITTEN
Monday, April 11, 2022ASSIGNED TO EXAMINER
Friday, November 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 17, 2021NEW APPLICATION ENTERED